Felicitex Therapeutics Inc. (FLCT)

Felicitex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2021	2020
Cash & Equivalents	0.01	0.04
Cash & Cash Equivalents	0.01	0.04
Cash Growth	-72.98%	-
Total Current Assets	0.01	0.04
Property, Plant & Equipment	0	0
Other Long-Term Assets	0	0
Total Long-Term Assets	0.01	0.01
Total Assets	0.02	0.05
Accounts Payable	0.23	0.13
Deferred Revenue	-	0.04
Current Debt	0.25	0.53
Other Current Liabilities	0.32	0.11
Total Current Liabilities	0.81	0.81
Total Liabilities	0.81	0.81
Total Debt	0.25	0.53
Debt Growth	-51.67%	-
Retained Earnings	-6.36	-6.64
Shareholders' Equity	-0.8	-0.76
Net Cash / Debt	-0.24	-0.49
Working Capital	-0.8	-0.77

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).